pharmacie et médicaments – Prise en charge des patients atteints du syndrome de Smith-Magenis

This written question concerns the healthcare and medication management for patients diagnosed with Smith-Magenis Syndrome. It seeks information on the current approach to treating individuals with this rare genetic disorder. The question addresses the needs of patients and their families, potentially impacting healthcare providers and pharmaceutical companies involved in rare disease treatment.